Article info
Viewpoint
Position statement on ethics, equipoise and research on charged particle radiation therapy
- Correspondence to Dr Mark Sheehan, The Ethox Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Rosemary Rue Building Headington, Oxford OX3 7LG, UK; mark.sheehan{at}ethox.ox.ac.uk
Citation
Position statement on ethics, equipoise and research on charged particle radiation therapy
Publication history
- Received December 12, 2012
- Revised July 24, 2013
- Accepted July 28, 2013
- First published September 17, 2013.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Response to ’Position statement on ethics, equipoise and research on charged particle therapy‘
- Proton beam therapy: the next disruptive innovation in healthcare?
- In search of social equipoise
- Local treatment failure after globe-conserving therapy for choroidal melanoma
- Learning health systems, clinical equipoise and the ethics of response adaptive randomisation
- Contextual equipoise: a novel concept to inform ethical implications for implementation research in low-income and middle-income countries
- Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma
- Research ethics for emerging trial designs: does equipoise need to adapt?
- Equipoise, standard of care and consent: responding to the authorisation of new COVID-19 treatments in randomised controlled trials
- Delaying and withholding interventions: ethics and the stepped wedge trial